Nanjing, China · Founded 2021 · Privately Held (backing)
Developer of clinical-stage biopharmaceuticals designed for innovative immunotherapies targeting respiratory diseases, including cancer. JSIAMA Biopharmaceuticals is based in Nanjing, China and was founded in 2021. Its last reported valuation was $66.2 million in Mar 2025. It has raised $6.9 million.
Last reported valuation
$66.2M
Oct 2026
Priced at
—
Total raised
$6.9M
Last round
—
Team — not yet on record
No current team members for JSIAMA Biopharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of JSIAMA Biopharmaceuticals with a free account
·Watch JSIAMA Biopharmaceuticals: the Monday email on marks, rounds and moves
